This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IBM Earnings Preview: What Wall Street's Thinking

Cantor Fitzgerald analyst Brian White (Buy, $220 PT)

"After the close this Thursday (7/17), IBM is scheduled to report its 2Q:14 earnings results with a conference call at 4:30 PM ET. In recent quarters, IBM's results have been characterized by revenue misses with lackluster profit performance driven by muted IT spending, weakness in hardware, softening trends in growth markets and other issues. Since the end of 2011, IBM's stock has risen by just 2% compared to a greater than 56% increase for the S&P 500 Index. In our view, either IBM needs to begin demonstrating to investors that the company is turning the corner or we believe a "shake up" at the company could occur."

JPMorgan analyst Tien-tsin Huang (Neutral, $197 PT)

"We expect 2Q hardware revenue to decline in mid twenties, inline with the decline rate in 1Q. We expect steady MIPS and revenue trends in System-z at the bottom of the refresh cycle, while Power systems could continue underperforming at the low end. We also estimate steady low single digit growth in s/w, as full quarter contribution from the Cloudant acquisition should be offset by tough comps. We expect continued mid single digit growth in Key Branded Middleware."

Credit Suisse analyst Kulbinder Garcha (Underperform, $160 PT)

"Our 2Q14 revenue/EPS estimates stand at $24.3bn/$4.33 vs. consensus of $24.1bn/$4.29. We continue to believe that IBM will see declining organic growth due to high mainframe exposure coupled with slower ramp to high value growth in services and software and struggle to achieve 100% FCF conversion. We reiterate our Underperform rating and $160 target price."

--Written by Chris Ciaccia in New York

>Contact by Email.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
IBM $165.00 0.16%
AAPL $125.69 -0.25%
FB $87.22 -0.38%
GOOG $525.02 0.41%
TSLA $267.88 -4.23%

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs